Manager, Oncology Early-Stage Clinical Scientist (12 months Secondment)

Why Patients Need You

The Oncology Early Stage (OES) Clinical Scientist (Manager, non-MD) plays a vital role in advancing small molecule and novel biologic therapies from first-in-human (FIH) through proof-of-concept (POC) studies. These studies include proof-of-mechanism (PoM) and early signals of efficacy (ESoE) in early oncology. By supporting the execution of these clinical studies, the role directly contributes to the development of innovative treatments that can significantly impact patients' lives. The Clinical Scientist collaborates across multiple disciplines—such as Biostatistics, Clinical Pharmacology, Precision Medicine, and Translational Oncology—ensuring a seamless and effective study process that ultimately benefits patients.

What You Will Achieve

As an OES Clinical Scientist Manager, you will contribute to the planning and execution of clinical studies, either independently or under the mentorship of a senior Clinical Scientist. You will be part of clinical study teams, helping to meet enrollment goals and study timelines. Your work will involve cross-functional collaboration and participation in clinical subteams to ensure integrated and efficient study delivery.

How You Will Achieve It

• Assist or lead the development and execution of simple to minimally complex clinical studies; support more complex studies by managing specific deliverables.

• Prepare or review study-related documents such as clinical protocols, informed consent forms, and training materials.

• Support or lead clinical data review efforts; collaborate with senior scientists on safety data collection and review.

• Provide technical support for clinical issues raised by internal and external stakeholders, in collaboration with the Global Development Lead (GDL).

• Maintain open and transparent communication with the study team to ensure successful study completion.

• Work with Pfizer compliance systems and registries (e.g., GDMS, pTMF, Clinical Trial Registries) and apply lessons learned.

• Support the development of publications, abstracts, and presentations as needed.

• Perform other duties related to clinical programs as assigned.

Qualifications

Must-Have

• Applicant must have a bachelor's degree with at least 4 years of
  experience; OR a master's degree with at least 2 years of experience; OR a PhD with 0+ years of experience.

• Comprehensive knowledge of GCP and ICH guidelines.

• Data listing review experience.

• Ability to work collaboratively in a fast-paced, team-based matrix environment and to function independently as appropriate.

• Proficiency in MS Office: Word, PowerPoint, SharePoint and Excel.

Nice-to-Have

• Good communication/interpersonal skills.

• Strong organizational skills and ability to prioritize work is a must.

Other Job Details: ​

• Last Date to Apply: October 23th, 2025

• Geography includes:

United States - California - South San Francisco

United States - Connecticut – Groton

United States - California - La Jolla

United States - Massachusetts - Cambridge

United States - New York - New York City

United States - Pennsylvania - Collegeville

United States - Washington – Bothell

United States - Remote

• Secondment: 12 months

• Eligible for Relocation Package: NO.  

• This secondment offers a valuable opportunity for professional growth. It will need to be funded by the secondee’s home market.

• If you are currently in a driving position with a fleet vehicle and this secondment does not require driving as an essential function of the position for 12 months or longer, you will be required to turn in your fleet vehicle for the duration of the non-driving secondment.  Please refer to the Fleet Policy and Procedures document for more information.

• There will be no change to your current work location.

• Work Location Assignment: Hybrid

NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS

10% travel

Relocation assistance may be available based on business needs and/or eligibility.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations.  These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value receiv